Universitätsklinikum Göttingen

Allergenic and microbiological hazards caused by skin markings during medical procedures? (2017) Maronna A, Psaier S, Geier J, Mahler V, Erfurt-Berge C Journal article Tumor regression grading after preoperative chemoradiotherapy as prognostic factor and individual-level surrogate for disease-free survival in rectal cancer: Results of the CAO/ARO/AIO-04 multicentre, open-label, randomised, phase 3 trial (2017) Fokas E, Stroebel P, Fietkau R, Ghadimi M, Liersch T, Grabenbauer G, Hartmann A, et al. Conference contribution Polycystic Ovary Syndrome (PCOS) in Juvenile and Adult Type 1 Diabetes in a German/Austrian Cohort (2017) Reinauer C, Bollow E, Froehlich-Reiterer E, Laubner K, Bergis D, Schöfl C, Kempe HP, et al. Journal article Is octocrylene a frequent contact allergen? (2017) Uter W, Lessmann H, Geier J Journal article Attention, cognitive control and motivation in ADHD: Linking event-related brain potentials and DNA methylation patterns in boys at early school age (2017) Heinrich H, Grunitz J, Stonawski V, Frey S, Wahl S, Albrecht B, Goecke TW, et al. Journal article Tumor Regression Grading After Preoperative Chemoradiotherapy as a Prognostic Factor and Individual-Level Surrogate for Disease-Free Survival in Rectal Cancer (2017) Fokas E, Stroebel P, Fietkau R, Ghadimi M, Liersch T, Grabenbauer GG, Hartmann A, et al. Journal article Vascular architecture as a diagnostic marker for differentiation of World Health Organization thymoma subtypes and thymic carcinoma (2017) Pfister F, Hussain H, Belharazem D, Busch S, Simon-Keller K, Becker D, Pfister E, et al. Journal article Immunotherapies in neuromyelitis optica spectrum disorder: efficacy and predictors of response (2017) Stellmann JP, Krumbholz M, Friede T, Gahlen A, Borisow N, Fischer K, Hellwig K, et al. Journal article Response-adapted consolidation with bortezomib after ASCT improves progression-free survival in newly diagnosed multiple myeloma (2017) Einsele H, Knop S, Vogel M, Mueller J, Kropff M, Metzner B, Langer C, et al. Journal article CONKO-005: Adjuvant Chemotherapy With Gemcitabine Plus Erlotinib Versus Gemcitabine Alone in Patients After R0 Resection of Pancreatic Cancer: A Multicenter Randomized Phase III Trial (2017) Sinn M, Bahra M, Liersch T, Gellert K, Messmann H, Bechstein W, Waldschmidt D, et al. Journal article